As previously reported, BTIG upgraded Snowflake (SNOW) to Buy from Neutral with a $220 price target After two-plus years of Snowflake dealing ...

BTIG lowered the firm’s price target on Pinstripes (PNST) to $2 from $3 and keeps a Buy rating on the shares. The firm notes that the company ...

BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth.

Wall Street is gearing up for another wave of blank check companies from seasoned and first-time sponsors, showing the ...

Medical Technology Analyst Zimmerman holds a virtual meeting with EVP & CFO Saccaro and Chief Investor Relations Officer Borders on February 21 ...

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already suggested that the semiconductor sector (SMH) — which is down 7% early Monday ...

BTIG highlights Wingstop (WING) as a top pick ahead of earnings, citing strong unit growth, supply chain benefits, & robust ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...

As of December 23, 2024, the average one-year price target for ImmunityBio is $14.54/share. The forecasts range from a low of $4.80 to a high of $31.50. The average price target represents an ...